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Abstract
The rapid growth of the corpus luteum (CL) after ovulation is believed to be mainly due to an increase in the size of
luteal cells (hypertrophy) rather than an increase in their number. However, the relationship between luteal growth
and the proliferation of luteal steroidogenic cells (LSCs) is not fully understood. One goal of the present study was to
determine whether LSCs proliferate during CL growth. A second goal was to determine whether luteinizing hormone
(LH), which is known have roles in the proliferation and differentiation of follicular cells, also affects the proliferation of
LSCs. Ki-67 (a cell proliferation marker) was expressed during the early, developing and mid luteal stages and some
Ki-67-positive cells co-expressed HSD3B (a steroidogenic marker). DNA content in LSCs isolated from the
developing CL increased much more rapidly (indicating rapid growth) than did DNA content in LSCs isolated from the
mid CL. The cell cycle-progressive genes CCND2 (cyclin D2) and CCNE1 (cyclin E1) mRNA were expressed more
strongly in the small luteal cells than in the large luteal cells. LH decreased the rate of increase of DNA in LSCs
isolated from the mid luteal stage but not in LSCs from the developing stage. LH suppressed CCND2 expression in
LSCs from the mid luteal stage but not from the developing luteal stage. Furthermore, LH receptor (LHCGR) mRNA
expression was higher at the mid luteal stage than at the developing luteal stage. The overall results suggest that the
growth of the bovine CL is due to not only hypertrophy of LSCs but also an increase in their number, and that the
proliferative ability of luteal steroidogenic cells decreases between the developing and mid luteal stages.
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Introduction
The corpus luteum (CL) is a transient endocrine gland
formed from a ruptured follicle after ovulation. The CL produces
progesterone (P4), which is required for the establishment and
maintenance of pregnancy in mammals [1,2]. The CL is one of
the fastest growing tissues in adult female mammals [3,4].
During the first 10 days of the 21-day bovine estrous cycle,
luteal weight increases by 20- to 30-fold [4]. The CL reaches
structural and functional maturity at the mid luteal stage (day
10) and then regresses at the end of the estrous cycle [5,6].
The CL mainly consists of (1) large luteal cells that are
presumably derived from follicular granulosa cells, (2) small
luteal cells that are presumably derived from follicular theca
cells and (3) non-steroidogenic cells such as endothelial cells,
fibroblasts and immune cells [7-10]. As the CL forms, it
becomes highly vascularized and the vascularization is
accompanied by a rapid proliferation of luteal endothelial cells
[11-13]. During growth of the CL, luteal steroidogenic cells
(LSCs) undergo dynamic changes [4,6], but there is no clear
evidence that they proliferate.
One approach to determining whether LSCs proliferate is to
examine genes that regulate cell proliferation and cell
differentiation. The regulation of both cell proliferation and
differentiation is essential for normal organogenesis in order to
obtain appropriate size, morphology and function [14]. For
tissue homeostasis, differentiation is usually coordinated with
the exit from the cell cycle [15]. The cell cycle is regulated by
cyclin-dependent kinases (CDK) and several proteins that
either stimulate or inhibit their activity [16]. Progression through
the G1-phase is controlled mainly by CDK4/6 and CDK2 in
association with CCND (cyclin D) and CCNE (cyclin E),
respectively. Entry of cells into the S-phase involves the
cooperation of CDK4/6 and D-type cyclins with CCNE-CDK2
complex [17,18]. In contrast to cyclins, CDK inhibitors such as
CDKN1A (p21Cip1) and CDKN1B (p27Kip1) are negative
regulators that arrest the cell cycle by binding to and inhibiting
the activity of cyclin-CDK complexes [19]. However, it is not
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known to what extent genes that regulate cell proliferation are
involved in controlling luteal growth.
Luteinizing hormone (LH) regulates a variety of ovarian
functions. Activation of the LH receptor (LHCGR) in follicular
cells by a preovulatory LH surge causes ovulation and rapidly
initiates a program of terminal differentiation of the granulosa
cells in a process termed luteinization [20]. Cessation of cell
proliferation during luteinization is associated with a
progressive loss of positive cell cycle regulators and with
increased expression of the CDK inhibitors CDKN1A and
CDKN1B [21,22]. LH also down-regulates CCND2 mRNA and
protein and induces CDK inhibitors in mice granulosa cells [23].
Thus, LH seems to play an important role in the proliferation
and differentiation of follicular cells. However, the role of LH in
the proliferation of LSCs is unclear.
To elucidate whether LSCs proliferate during CL growth, we
examined 1) the expression of KI-67, a cell proliferation
marker, and HSD3B (also known as 3β-HSD), which is a
marker specific for steroidogenic cells, in bovine luteal tissue,
2) the expression of cell cycle-related genes and PTEN
(phosphatase and tensin homolog; a key regulator of cell
proliferation) in freshly isolated LSCs and 3) the proliferation of
cultured LSCs isolated from the developing and mid CL. To
determine which cell types of LSCs proliferate, we compared
cell cycle-related genes and PTEN mRNA levels between large
and small luteal cells. We also examined the effects of LH on
the proliferation of cultured LSCs and their expression of cell
cycle-related genes.
Materials and Methods
Ethics Statement
In this study, we did not perform any animal experiments.
The ovaries were collected from non-pregnant Holstein cows at
a local abattoir (Tsuyama Meat Center) in accordance with
protocols approved by local institutional animal care. All the
samples and data analyzed in the present study were obtained
with the permission of the above center.
Collection of CL
The stages of the estrous cycle were identified by
macroscopic observation of the ovary and uterus as described
previously [24]. CL tissues were collected from cows at five
different stages of the estrous cycle (early: Days 2-3;
developing: Days 5-7; mid: Days 9-12; late: Days 15-17;
regressed luteal stage: Days 19-21). For cell culture
experiments, the ovaries with CL were submerged in ice-cold
physiological saline and transported to the laboratory.
For immunohistochemistry, the CL tissues were immediately
separated from the ovaries and dissected free of connective
tissue. Tissue samples were fixed in 10% (v/v) neutral
phosphate buffer formalin (pH 7.0) for 24 h at room
temperature and then embedded in paraffin wax. The samples
were cut into 4 &[mu]m sections and mounted onto glass
microscope silanized slides (Dako).
Cell isolation
Luteal tissue was enzymatically dissociated and luteal cells
were cultured as described previously [25]. The luteal cells
were suspended in a culture medium, DMEM, and Ham’s F-12
medium [1:1 (vol/vol); Sigma-Aldrich, Inc., St. Louis, MO; no.
D8900] containing 5% calf serum (Life Technologies, Inc.,
Grand Island, NY; no. 16170-078) and 20 μg/ml gentamicin
(Life Technologies; no. 15750-060). Cell viability was greater
than 85% as assessed by trypan blue exclusion. The cells in
the cell suspension consisted of about 75% small luteal cells,
20% large luteal cells, 5% endothelial cells or fibrocytes, and
no erythrocytes. Some of the freshly isolated LSCs were
washed with PBS (-) then used for gene analysis. Small and
large luteal cells were separately collected from freshly isolated
LSCs under a microscope. About 300 cells were collected for
each cell type. Cell size was measured by ocular and stage
micrometers. Small and large luteal cells were identified by
their sizes: <20 μm and >35 μm, respectively.
To confirm the identities of the small and large luteal cells,
we determined the expression levels of oxytocin mRNA, which
is highly expressed in large luteal cells, and LHCGR mRNA,
which is highly expressed in small luteal cells. These
expressions were as expected.
Cell culture
The dispersed luteal cells were seeded at 0.5 × 105 viable
cells per ml in 4-well cluster dishes (Nunc, Roskilde, Denmark;
no. 176740) for cell proliferation assay or 2 x 105 viable cells
per ml in 24-well cluster dishes (Coster, Cambridge, USA; no.
3524) for gene analysis. They were then cultured in a
humidified atmosphere of 5% CO2 in air at 37.5 C in a N2-O2-
CO2-regulated incubator (ESPEC Corp., Osaka, Japan; no.
BNP-110). After 16 h of culture, the medium was replaced
DMEM/F-12 containing 5% calf serum (for cell proliferation
assay) or DMEM/F-12 containing 0.1% [w/v] BSA, 5 ng/ml
sodium selenite, 5 μg/ml transferring and 2 μg/ml insulin (for
gene analysis) with or without LH (10 ng/ml).
Immunohistochemistry and immunofluorescence
Expression of KI-67, a cell proliferation marker, in bovine CL
was demonstrated by immunohistochemistry. The 4 μm
sections were deparaffined, rehydrated in a graded series of
ethanol and washed in tap-water. Antigen retrieval was
performed by placing the slides in boiling buffer (0.01 M citrate
acid, pH 6) for 15 min. Endogenous peroxidase activity was
quenched in methanol with 0.3% H2O2 for 10 min. Nonspecific
binding was blocked at room temperature for 1 h in PBS-5%
skim milk. Sections were incubated with an anti-mouse KI-67
antibody (1 : 200, Dako; M7240) overnight at 4 C. After
incubation, the sections were washed with PBS and incubated
with ImmPRESS UNIVERSAL reagent (Vector Laboratories;
MP-7500) for 30 min according to the manufacturer’s
instructions. The sections were visualized with 0.05% 3,3-
diaminobenzidine tetrahydrochloride (DAB) in 0.01 M PBS (pH
7.4) containing 0.01% H2O2.
Co-expression of KI-67 and HSD3B was detected by
immunofluorescence. The sections were deparaffined,
rehydrated in a graded series of ethanol and washed in tap-
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water. Antigen retrieval was performed by placing the slides in
boiling buffer (0.01 M citrate acid, pH 6) for 15 min. Nonspecific
binding was blocked at room temperature for 1 h in PBS-5%
skim milk. Sections were incubated with the anti-mouse KI-67
(described above) and anti-goat HSD3B (1 : 100, Santa Cruz;
sc-30820) overnight at 4 C. After incubation, the sections were
washed with PBS three times followed by 1 h incubation with
an appropriate secondary antibody diluted at 1 : 1000 (anti-
mouse or goat IgG conjugated with Alexa 488 or 594) at room
temperature in the dark. Coverslips were mounted on slides
with ProLong Gold antifade reagent with DAPI (Invitrogen;
P36935).
Cell proliferation assay
Cellular proliferation of bovine developing and mid luteal
cells was demonstrated by spectrophotometric method of
Labarca and Paigen [26]. Bovine luteal steroidogenic cells
isolated from developing and mid stage CL were cultured for 1,
4, 7 and 10 days, and DNA contents were measured at the end
of culture.
RNA isolation and cDNA synthesis
Total RNA was prepared from bovine CL throughout estrous
cycle and isolated LSCs using TRIZOL reagent according to
the manufacturer’s directions (Invitrogen, Carlsbad, CA; no.
15596-026). A small amount of total RNA was prepared from
separately collected small luteal cells and large luteal cells
using PureLink RNA micro scale kit (Invitrogen; no. 12183016)
according to the manufacturer’s directions. The total RNA was
reverse transcribed using a ThermoScript RT-PCR system
(Invitrogen; no. 11146-016).
Real-time PCR
Gene expression was measured by real-time PCR using the
MyiQ (Bio-Rad, Tokyo, Japan) and the iQ SYBR Green
Supermix (Bio-Rad; No. 170-8880) starting with 1 ng of
reverse-transcribed total RNA as described previously [27].
Standard curves of sample cDNA were generated serial
dilutions (1:2 to 1:1000). The expression of GAPDH was used
as an internal control. 20 bp primers with 50-60% GC-contents
were synthesized (Table 1). The PCR contents were 95 C for
15 min, followed by 45 cycles of 94 C for 15 sec, 55 C for 30
sec and 72 C for 30 sec. Use of the QuantiTect SYBR Green
PCR system at elevated temperatures resulted in reliable and
sensitive quantification of the PCR products with high linearity.
Statistical analysis
All experimental data are shown as the mean ± sem. The
statistical significance of differences in the contents of DNA
and protein throughout the estrous cycle and the cellular
proliferation of bovine mid luteal cells were assessed by
ANOVA followed by a Fisher protected least significant
difference procedure (PLSD) as a multiple comparison test.
Results
Luteal weight, DNA and protein contents of bovine CL
throughout the estrous cycle
The CL weight and protein contents (an index of cell size)
increased from the early to late luteal stages and then
decreased toward the regressed luteal stage, whereas DNA
contents (an index of cell number) only increased from the
early to developing luteal stages (Table 2).
KI-67 expression in the CL throughout the estrous
cycle
KI-67-positive cells were localized in the CL from the early,
developing and mid luteal stages and the rate of KI-67 staining
was greater in the early and developing CL than in the mid CL
(Figure 1A-F). In contrast, only a few KI-67-positive cells were
Table 1. Primers used in quantitative RT-PCR.
Gene Primer Sequence (5’-3’) Accession no.
Product
(bp)
CCND2 Forward TTCAGCAGGATGAGGATGTG NM001076372 146
 Reverse ACGGTACTGCTGCAGGCTAT   
CCNE1 Forward TTCCTGCTGAAGATGCACAC NM001192776 78
 Reverse CTTTCTTTGCTTGGGCTTTG   
CDKN1A Forward AGCATCCTTTGCTTTCCTCA NM001098598 72
 Reverse AGAGAGTGCCACCCAGAGAA   
CDKN1B Forward AGATGTCAAACGTGCGAGTG NM001100346 104
 Reverse GCCAAAGAGGTTTCTGCAAG   
PTEN Forward TGACTGCTCCATCTCCTGTG XM002698370 119
 Reverse CCACAGCAGGTACACGATTG   
LHCGR Forward CTAGCCATCACGGGAAATGT U20504 102
 Reverse GTCTGCAAAGGAGAGGTTGC   
Oxytocin Forward CTTCTCCCAGCACTGAGACC M25648.1 103
 Reverse CCGGCTTTATTTCATTGTCA   
doi: 10.1371/journal.pone.0084186.t001
Table 2. Luteal weight, DNA and protein contents of bovine
CL throughout the estrous cycle.
 Early Developing Mid Late Regressed
Wet tissue
weight 0.86±0.15
a 2.29±0.20b 3.57±0.20c 4.25±0.88c 0.84±0.06a
(g/CL)      
DNA
contents
(mg/CL)
0.52±0.09a 2.00±0.55bc 2.21±0.18c 2.88±0.32c 1.10±0.27b
(Index of
hyperplasia)      
Protein
contents 55.5±28.4
a 246.7±50.9b 396.8±13.2c 468.1±70.5c 71.3±7.2a
(mg/CL)      
doi: 10.1371/journal.pone.0084186.t002
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localized in the late CL and no mitotic activity was observed in
the regressed CL (Figure 1G-J).
Double immunofluorescent staining of KI-67 and
HSD3B
The steroidogenic enzyme HSD3B was present in the CL
tissues at the early, developing and mid stages. About 2% of
KI-67 positive cells that also expressed HSD3B in the early and
developing CL (Figure 2A, B, D) and less than 1% of cells co-
expressed both cell markers in the mid CL (Figure 2C, D).
Expression of cell cycle-related genes and PTEN in
bovine freshly isolated LSCs
CCND2 and CCNE1 mRNA were expressed more strongly in
the LSCs from developing CL than in the LSCs from mid CL.
On the other hand, CDKN1A tended to be expressed more
strongly in the LSCs from mid CL than in the LSCs from
developing CL. Furthermore, PTEN was expressed more
strongly in the LSCs from mid CL than in the LSCs from
developing CL (Figure 3).
Expression of cell cycle-related genes in bovine freshly
isolated small and large luteal cells
The identities of small and large luteal cells, were confirmed
by the expressions of oxytocin mRNA and LHCGR mRNA,
respectively (Figure 4A). The cell cycle-progressive genes
CCND2 and CCNE1 mRNA were expressed more strongly in
the small luteal cells than in the large luteal cells (Figure 4B).
Cellular proliferation of cultured bovine LSCs
DNA contents were used as an index of cell proliferation.
Liner increases in DNA contents of cultured LSCs were
observed in control and LH-treated cells isolated from both the
developing and mid luteal stages, although the DNA contents
of the mid luteal stage were less than those of the developing
stage (Figure 5A). LH decreased the DNA contents in bovine
LSCs obtained from the mid luteal stage but not from the
developing luteal stage (Figure 5H, I). The LSCs increased
after they were seeded (Figure 5B-E). More than 95% of the
cells positively immunostained with HSD3B (Figure 5F).
Figure 1.  KI-67 expression in the bovine CL.  Representative images of immunohistochemical staining for KI-67 in the bovine CL
throughout the estrous cycle (A, B; early, C, D; developing, E, F; mid, G, H; late, I, J; regressed luteal stages). Scale bars represent
100 μm (low magnitude) and 50 μm (high magnitude).
doi: 10.1371/journal.pone.0084186.g001
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Figure 2.  KI-67 and HSD3B expression in the bovine CL.  Representative images of double-immunohistochemical staining for
KI-67 and HSD3B in early (A), developing (B) and mid (C) bovine CL. Normal horse serum was used as a negative control (D).
Scale bars represent 50 μm. (E) Percentage of KI-67 positive LSCs in the bovine CL (mean±SEM, n=3 experiments). Percentages
in each luteal stage were derived from dividing the number of Ki-67 and HSD3B positive cells by total number of HSD3B positive
cells. Cells were counted in three randomly chosen areas. Different superscript letters indicate significant differences (P<0.05).
doi: 10.1371/journal.pone.0084186.g002
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Effect of LH on cell cycle-related genes and PTEN in
bovine LSCs
LH decreased CCND2 mRNA level in LSCs isolated from at
the mid luteal stage, but not in LSCs isolated from the
developing luteal stage. LH did not affect other LSC-expressed
genes such as CCNE1, CDKN1A, CDKN1B and PTEN in either
the developing or mid LSCs (Figure 6).
LHCGR mRNA expression in the CL throughout the
estrous cycle
LHCGR mRNA was expressed in bovine CL throughout the
estrous cycle, and was significantly higher (P<0.05) at the mid
luteal stage than at the other luteal stages (Figure 7).
Discussion
While the corpus luteum (CL) has a central role in
establishing and maintaining pregnancy, the mechanisms of CL
growth are not completely understood. Although cells positive
for KI-67 (a cell proliferation marker) have been reported in the
growing CL [4,28,29], there are still opposite opinion in this
matter because of lacking in evidence [6]. The present results
clearly show that bovine LSCs proliferate during CL growth.
First, we observed cells that were positive for both HSD3B, a
steroidogenic marker, and KI-67 in the early, developing and
mid CL (Figure 2). Second, cell cycle progressive genes such
as CCND2 and CCNE1 were expressed more strongly in LSCs
obtained from the developing CL than in LSCs obtained from
the mid CL (Figure 3). Third, cultured bovine LSCs isolated
from the bovine CL proliferated until they reached confluence
(Figure 5).
To confirm that LSCs proliferate during CL growth, we first
investigated the DNA and protein contents in luteal tissues that
provide a good index of luteal growth, since both the DNA and
protein contents have been correlated with luteal weight [4,29].
Although CL weight and protein contents increased until the
mid luteal stage, DNA contents stopped increasing at the
developing luteal stage (Table 2). Double-immunostaining for
HSD3B and KI-67 provided more direct evidence for the
proliferation of LSCs during CL growth. HSD3B and Ki-67 co-
positive cells were more abundant at the developing luteal
stage than at the mid luteal stage (Figure 2). These results are
consistent with those of previous studies [4,28,29]. In addition,
cell cycle progressive genes such as CCND2 and CCNE1
mRNA were expressed more strongly in the LSCs taken from
the developing CL (Figure 3) and LSCs from the developing CL
proliferated faster than those from the mid CL (Figure 5A).
Luteal growth is generally thought to depend on hypertrophy
rather than hyperplasia [30-32]. However, the results of the
previous and present studies suggest that bovine luteal growth
is due to both an increase in cell number and hypertrophy
during the early and developing luteal stages.
The main difference between large and small luteal cells in
bovine CL is their diameters [33-36]. The smallest diameter of
large luteal cells is 25 μm [37] and the average diameters of
the large and small luteal cells were 38.4 μm and 17.2 μm,
respectively [9]. The large luteal cells and the small luteal cells
are believed to be derived from follicular granulosa cells and
follicle theca cells, respectively [5,38]. It has been reported that
the cell cycle of granulosa cells is arrested after the ovulatory
stimulus in mouse [23], rat [39] and rhesus macaques [40]. The
theca cells were found to proliferate faster than granulosa cells
after inducing in vitro luteinization by 5% fetal bovine serum　
[41]. Because the size of the KI-67-positive steroidogenic cells
were less than 20 μm in the present study, the proliferating
LSCs seem to be mostly small luteal cells. Furthermore, cell
proliferation progressive genes were expressed more strongly
in the small luteal cells than in the large luteal cells (Figure 4).
Thus, the present findings also support the idea that only small
luteal cells proliferate during luteal development. The
Figure 3.  Cell cycle-related genes and PTEN expression in bovine freshly isolated LSCs.  Fold differences of cell cycle-
related genes such as CCND2, CCNE1, CDKN1A, CDKN1B and tumor suppressor gene PTEN mRNA between freshly isolated
developing LSCs and mid LSCs. Single and double Asterisks indicate significant differences (* ; P<0.1, ** ; P<0.05), as determined
by ANOVA followed by Fisher’s PLSD as a multiple comparison test.
doi: 10.1371/journal.pone.0084186.g003
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differences between the proliferation of large and small luteal
cells suggest that the mechanisms of terminal differentiation
are distinct between these two types of cells.
In contrast to the early and developing luteal stages, the mid
luteal stage was characterized by relatively few KI-67-positive
LSCs (Figure 2) and the rate of increase of DNA contents was
slower in LSCs isolated from the mid CL than in LSCs isolated
from the developing CL (Figure 5A). In addition, cell cycle
progressing genes (CCND2 and CCNE1) were expressed
more strongly at the developing luteal stage than at the mid
luteal stage (Figure 3). These findings indicate that the terminal
differentiation of bovine luteal cells occurs between the
developing and mid luteal stages. Since LH induces the
differentiation of proliferative follicular cells to non-proliferative
luteal cells [21,22], LH is one of the possible substances
controlling cellular proliferation of LSCs. In the present study,
LH treatment decreased the proliferation of cultured bovine
LSCs isolated from the mid CL coincident with down-regulating
the CCND2 level (Figure 5I and Figure 6B). This result
suggests that the cellular proliferation of LSCs is down-
regulated by LH. Furthermore, LHCGR mRNA expression was
higher at the mid luteal stage than at the other luteal stage
(Figure 7). Based on the above findings, the increased LHCGR
and its activation by LH decrease the cellular proliferation of
LSCs and assist the terminal differentiation of bovine LSCs.
Further studies are needed to clarify the relationship between
Figure 4.  Cell cycle-related genes and PTEN expression in small and large luteal cells.  Fold differences of oxytocin, LHCGR
and cell cycle-related genes such as CCND2, CCNE1, CDKN1A, CDKN1B and tumor suppressor gene PTEN mRNA between large
luteal cells and small luteal cells isolated from developing and mid luteal stages. Asterisks indicate significant differences (* P<0.05),
as determined by ANOVA followed by Fisher’s PLSD as a multiple comparison test.
doi: 10.1371/journal.pone.0084186.g004
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the LH receptor expression and luteal steroidogenic cells
proliferation.
The PI3K/AKT pathway induces cell proliferation by
modulating the expressions of cell cycle-related genes [42] and
PTEN is a negative regulator of the PI3K/AKT pathway [43].
Thus, PTEN is one of the key regulators of cell proliferation.
Our finding that PTEN mRNA level was higher in the freshly
isolated LSCs obtained from developing stage CL than that
from mid luteal stage CL (Figure 3) suggests that the PTEN
expression level changes dramatically between the developing
and mid luteal stages. While cellular proliferation of LSCs was
down-regulated by LH, LH did not affect the PTEN mRNA
expression in the present study. Recently, PTEN expression
levels have been shown to be tightly controlled by biologically
active RNAs such as miR-106-25 microRNA [44]. For example,
miR-25 strongly down-regulates PTEN expression in
melanoma cells [45]. Furthermore, miR-25 was expressed
more strongly at the early luteal stage CL than at the late luteal
stage CL in sheep [46]. These findings suggest that miR-25 is
the one of the key regulators of PTEN. Further studies are
needed to clarify the exact mechanisms regulating PTEN
expression as well as cell cycle-related genes in bovine CL.
In conclusion, our results indicate that luteal growth depends
not only on hypertrophy of LSCs but also on an increase in the
number of small luteal cells, and suggest that the proliferative
ability of luteal steroidogenic cells changes between the
developing and mid luteal stages.
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used as a negative control (G). (H) and (I) show the effect of LH (10 ng/ml) on cellular proliferation of bovine luteal cells isolated
from the developing and mid CL, respectively (mean±SEM, n-5 experiments). Asterisks indicate that LH had a significant effect on
DNA concentration (P<0.05), as determined by ANOVA followed by Fisher’s PLSD as a multiple comparison test.
doi: 10.1371/journal.pone.0084186.g005
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Figure 6.  Effect of LH on cell cycle-related genes and PTEN expression in cultured LSCs.  CCND2, CCNE1, CDKN1A,
CDKN1B and PTEN mRNA in cultured LSCs isolated from the developing (A) and mid (B) CL (mean±SEM, n=4 experiments). The
cells were exposed to LH (10 ng/ml) for 24 h. Asterisks indicate significant differences (P<0.05), as determined by ANOVA followed
by Fisher’s PLSD as a multiple comparison test.
doi: 10.1371/journal.pone.0084186.g006
Figure 7.  LHCGR expression in the bovine CL.  Relative levels of LHCGR mRNA in bovine CL throughout the estrous cycle
(n=4). Asterisks indicate significant differences (P<0.05), as determined by ANOVA followed by Fisher’s PLSD as a multiple
comparison test.
doi: 10.1371/journal.pone.0084186.g007
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